Finding New Pathways to a More Inclusive and Humane Economy
After the rise of the technological revolution, social entrepreneurs are now heralding a new revolution. To address societal issues at their roots, they use the codes and tools from the economic world to advance their missions for the common good. Over two decades, they have demonstrated the...
Today, there are 7000 rare diseases affecting 250 millions people in Europe and only 5% have an approved treatment. Caroline is accelerating the cost-effective development of unexplored therapeutic opportunities in rare diseases by addressing key translational gaps and clinical development...
Leggi tutto
Oskar is leveraging the Norwegian healthcare system to attend to currently underprioritized patients with mild and moderate symptoms of the most common mental health disorders. By also developing a web-based platform for experts to create and share treatments, Oskar is building a library of...
Leggi tutto
Aled Edwards: Open Source Leads to Medicine Discovery for Kids' Rare Diseases
Billions are lost to patenting and lab secrets while children unnecessarily die. Thanks to Aled Edwards, stakeholders join secret-free forces to create affordable drugs.
Supporting Health Outcomes with an Open Mind and an Open Source Approach
Last week we introduced the first in a series of interviews covering open source thinking over at Stanford Social Innovation Review (SSIR), and today we're bringing you the second. Again moderated by two of our favorites, Roshan Paul and Alexa Clay, this week's interview is all about health care...
Culture Matters: 5 Tips for Facilitating Collaboration
As the CEO of Genetic Alliance, Ashoka Fellow Sharon Terry is determined to accelerate research, drug development, treatment, advocacy, and support for genetic disease. She’s found a way to dissolve the boundaries between disease-specific family foundations and advocacy organizations, universities...
Santé : cette chercheuse traque les médicaments dormants contre les maladies rares et les réactive
>> Pour en savoir plus sur Caroline Kant Qu'une maladie affecte 2000 ou 20 millions de personnes, les droits au traitement médical devraient être les mêmes. C'est le but de la Fondation EspeRare, une association basée à Genève et créée en 2013 par Caroline Kant, qui réveille les médicaments «...
Caroline Kant: caring for children suffering from life-threatening diseases
While working at Merck Serono in the research and development (R&D) knowledge management department, Caroline Kant discovered many drugs sitting on the company’s shelves, waiting to be researched on, and which could become part of a much needed solution to treat rare diseases.
Caroline Kant: traque les médicaments dormants contre les maladies rares, et les réactive
Alors qu'elle travaille au département recherche et développement de Merck Serono, un laboratoire phamarceutique, Caroline Kant découvre l’existence de nombreux traitements, en repos sur les étagères du laboratoire. "Dormantes", ces molécules sont pourtant prêtes à être l’objet de recherches pouvant...
The Freedom to Innovate: The Contributions of Social Entrepreneurs to the Field of Global Public Health
Ashoka Vice-President of Global Marketing Beverly Schwartz has contributed a chapter to a new book on the role of community-based organizations and non-governmental organizations in public health. Igniting the Power of Community: The Role of CBOs and NGOs in Global Public Health, edited by Paul...